• 1
    Kovarik J, Siegrist CA. Immunity in early life. Immunol Today 1998; 19:1502.
  • 2
    Adkins B. T-cell function in newborn mice and humans. Immunol Today 1999; 220:3305.
  • 3
    Harris DT, Schumacher MJ, Locascio J et al. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc Natl Acad Sci USA 1992; 89:1000610.
  • 4
    Wilson CB, Lewis DB. Basis and implications of selectively diminished cytokine production in neonatal susceptibility to infection. Rev Infec Dis 1990; 12:S410–S420.
  • 5
    Steinman RM. The dendritic cell and its role in immunogenicity. Ann Rev Immunol 1991; 8:27196.
  • 6
    Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:24552.
  • 7
    Romani N, Gruner S, Brang D et al. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994; 180:8393.
  • 8
    Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994; 179:110918.
  • 9
    Goriely S, Vincart B, Stordeur P et al. Deficient IL-12 (p35) gene expression by dendritic cells derived from neonatal monocytes. J Immunol 2001; 166:21416.
  • 10
    Langenkamp A, Messi M, Lanzavecchia A, Sallusto F. Kinetics of dendritic cell activation: impact on priming of Th1, Th2 and non-polarised cells. Nature Immunol 2000; 1:3116.
  • 11
    Baraff LJ, Leake RD, Burstyn DG et al. Immunologic responses to early and routine DTP immunization in infants. Pediatrics 1984; 73:3742.
  • 12
    Hart DJ. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 1997; 90:324587.
  • 13
    Rhasselt V, Buelens C, Willems F et al. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. J Immunol 1997; 158:291925.
  • 14
    Liu E, Tu W, Law HK, Lau YL. Decreased yield, phenotypic expression and function of immature monocyte-derived dendritic cells in cord blood. B J Haematol 2001; 113:2406.
  • 15
    Liu E, Tu W, Law HK, Lau YL. Changes of CD14 and CD1a expression in response to IL-4 and granulocyte-macrophage colony-stimulating factor are different in cord blood and adult blood monocytes. Ped Res 2001; 50:1849.
  • 16
    Hunt DW, Huppertz HI, Jiang HJ, Petty RE. Studies of human cord blood dendritic cells: evidence for functional immaturity. Blood 1994; 84:433343.
  • 17
    Petty RE, Hunt DW. Neonatal dendritic cells. Vaccine 1998; 16:137882.
  • 18
    Wright SD. Toll, a new piece in the puzzle of innate immunity. J Exp Med 1999; 189:6059.
  • 19
    Burchett SK, Weaver WM, Westall JA, Larsen A, Kronheim S, Wilson CB. Regulation of tumor-necrosis factor/cachectin and IL-1 secretion in human mononuclear phagoctes. J Immunol 1988; 140:347381.
  • 20
    Adkins B, Biu Y, Guevara P. The generation of Th memory in neonates versus adults: prolonged primary Th2 effector function and impaired development of Th1 memory effector function in murine neonates. J Immunol 2001; 166:91825.
  • 21
    Adkins B, Du RQ. Newborn mice develop balanced Th1/Th2 primary effector responses in vivo but are biased to Th2 secondary responses. J Immunol 1998; 160:421724.
  • 22
    Adkins B, Biu Y, Cepero E, Perez R. Exclusive Th2 primary effector function in spleens but mixed Th1/Th2 function in lymph nodes of murine neonates. J Immunol 2000; 164:234753.
  • 23
    Sornasse T, Larenas PV, Davis KA, De Vries JE, Yssel H. Differentiation and stability of T helper 1 and 2 cells derived from naïve human neonatal CD4+ T cells, analysed at the single-cell level. J Exp Med 1996; 184:47383.
  • 24
    Ridge JP, Fuchs EJ, Matzinger P. Neonatal tolerance revisited. Turning on newborn T cells with dendritic cells. Science 1996; 271:17236.
  • 25
    Min B, Legge KL, Pack C, Zaghouani H. Neonatal exposure to a self-peptide-immunoglobulin chimera circumvents the use of adjuvant and confers resistance to autoimmune disease by a novel mechanism involving interleukin 4 lymph node deviation and interferon gamma mediated splenic anergy. J Exp Med 1998; 188:200717.
  • 26
    Arulanandam BP, Van Cleave VH, Metzger DW. IL-12 is a potent neonatal vaccine adjuvant. Eur J Immunol 1999; 29:25664.DOI: 10.1002/(sici)1521-4141(199901)29:01<256::aid-immu256>;2-g
  • 27
    Arulanandam BP, Mittler JN, Lee WT, O’Toole M, Metzger DW. Neonatal administration of IL-12 enhances the protective efficacy of antiviral vaccines. J Immunol 2000; 164:3698704.
  • 28
    Donckier V, Flamand V, Desalle F et al. IL-12 prevents neonatal induction of transplantation tolerance in mice. Eur J Immunol 1998; 28:142630.DOI: 10.1002/(sici)1521-4141(199804)28:04<1426::aid-immu1426>;2-p
  • 29
    Corinti S, Albanesi C, La Sala A, Pastore S, Girolomoni G. Regulatory activity of autocrine IL-10 on dendritic cell functions. J Immunol 2001; 166:43128.
  • 30
    D’Amico G, Frascaroli G, Bianchi G et al. Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys. Nat Immunol 2000; 1:38791.